Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study Eun-Gyoung HongKyung-Wan MinHak Chul Jang Original Research Open access 21 March 2024 Pages: 1967 - 1982
Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review Mustafa KhasrawPriyanka YalamanchiliEnriqueta Felip Review Open access 21 March 2024 Pages: 1815 - 1842
‘Totality of Evidence’ Approach in the Development of GP2017, an Approved Adalimumab Biosimilar Norman GaylisCharlotte BothPaul Yamauchi Review Open access 21 March 2024 Pages: 1795 - 1814
Enhancing Drug Management, Cost Savings, and Staff Satisfaction in Anesthesiology: A Quality Improvement Project in a Chinese Tertiary Hospital Xiaomin XingHaijun QuFanbo Jing Original Research 18 March 2024 Pages: 1953 - 1966
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor Gilles SallesJenny M. H. ChenBijal Shah Original Research Open access 18 March 2024 Pages: 1938 - 1952
Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data Brian G. M. DurieShaji K. KumarThierry Facon Original Research Open access 18 March 2024 Pages: 1923 - 1937
Correction to: Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis Claire WatkinsTatiana PauloMarloes Bagijn Correction Open access 13 March 2024 Pages: 2084 - 2085
Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis Awad AlshahraniNaji KholaifMoeber Mahzari Correction Open access 13 March 2024 Pages: 2083 - 2083
Perioperative and Long-Term Outcomes in Patients Undergoing Synchronous Carotid Endarterectomy and Coronary Artery Bypass Grafting: A Single-Center Experience Paimann NawroziThomas RatschillerAndreas Zierer Original Research Open access 13 March 2024 Pages: 1911 - 1922
Adverse Drug Events Observed with the Newly Approved Remimazolam in Comparison to Propofol for General Anesthesia in Patients Undergoing Surgery: A Meta-analysis Lidan HuangHong LiuSong Tao Original Research 13 March 2024 Pages: 1896 - 1910
Correction to: PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly Dermot O’ToolePamela L. KunzAlly Prebtani Correction 13 March 2024
Comparison of Healthcare Costs for Women with Treated Versus Untreated Vasomotor Symptoms Due to Menopause Aki ShiozawaShayna MancusoHelen M. Trenz Original Research Open access 11 March 2024 Pages: 1885 - 1895
The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis Larry CulpepperAshley MartinMousam Parikh Original Research Open access 11 March 2024 Pages: 1860 - 1884
Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era: A Narrative Review Jessica R. AllegrettiJessica H. BradyAlvin Wells Review Open access 11 March 2024 Pages: 1775 - 1794
Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study Motohiro OzoneSusumu HirotaNaohisa Uchimura Original Research Open access 09 March 2024 Pages: 1728 - 1745
Incidence and Costs of Clinically Significant Events with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study Daniel J. SimmonsStephen J. ValerioJanvi Sah Original Research Open access 05 March 2024 Pages: 1711 - 1727
Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis Yue PanXinxin ZhangLei Cheng Original Research 05 March 2024 Pages: 1698 - 1710
Left Atrial Strain Insights in Atrial Fibrillation and the Interplay with Metabolic Syndrome Hyun-Jin KimHyun-Sun Kim Original Research 05 March 2024 Pages: 1685 - 1697
Satisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab Sanjay ChabraJulie BirtW. Chad Cragun Original Research Open access 05 March 2024 Pages: 1672 - 1684
An Update on Stiripentol Mechanisms of Action: A Narrative Review Alexandre BacqAntoine DepaulisMarc Verleye Review Open access 05 March 2024 Pages: 1351 - 1371
Patient and Clinician Perspectives: To Create a Better Future for Chronic Kidney Disease, We Need to Talk About Our Kidneys Pamela R. KushnerJane DeMeisNavdeep Tangri Commentary Open access 05 March 2024 Pages: 1318 - 1324
Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT Dédée F. MurrellPascal JolyArsalan Shabbir Study Protocol Open access 05 March 2024
Correction to: Association of Patient Satisfaction with Cataract Grading in Five Types of Multifocal IOLs Sana NiaziZisis GatzioufasFarideh Doroodgar Correction 02 March 2024 Pages: 1774 - 1774
Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH) Seung-June OhSung Tae ChoBudiwan Sumarsono Original Research Open access 02 March 2024 Pages: 1652 - 1671
Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies Nandita KheraMarie Louise EdwardsUsama Gergis Original Research Open access 01 March 2024 Pages: 1637 - 1651
Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative Breast Cancer Yan LiShengjie YangXinghe Wang Original Research 29 February 2024 Pages: 1621 - 1636
Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer: An Updated Systematic Review and Network Meta-Analysis André L. F. Azeredo-da-SilvaVictor Hugo F. de JesusPatricia K. Ziegelmann Original Research Open access 26 February 2024 Pages: 1606 - 1620
Improved Quality of Life in Patients with Psoriasis Receiving Apremilast: Real-World Data from the Netherlands Juul M. P. A. van den ReekRobert J. T. van der LeestElke M. G. J. de Jong Original Research 24 February 2024 Pages: 1594 - 1605
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma Hermann EinselePhilippe MoreauMaria-Victoria Mateos Original Research Open access 24 February 2024 Pages: 1576 - 1593
Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause Neil M. SchultzAntonia MorgaStephanie E. Rhoten Original Research Open access 24 February 2024
Correction to: Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia Tawfeg Ben-OmranLuis MasanaRaul D. Santos Correction Open access 20 February 2024 Pages: 1765 - 1769
Evolving Role of Viltolarsen for Treatment of Duchenne Muscular Dystrophy LeighAnn Y. VincikAlexandra D. DautelAlan D. Kaye Review 20 February 2024 Pages: 1338 - 1350
Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives Rebecca MooreJoshua PoulsenJane B. Lane Commentary Open access 20 February 2024 Pages: 1305 - 1317
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials Takayuki HamanoYusuke YamaguchiJonathan Barratt Original Research Open access 16 February 2024 Pages: 1553 - 1575
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan Takayuki HamanoYusuke YamaguchiTadao Akizawa Original Research Open access 16 February 2024 Pages: 1526 - 1552
Assessing Itch Severity: Content Validity and Psychometric Properties of a Patient-Reported Pruritus Numeric Rating Scale in Atopic Dermatitis Alissa RamsJessica BaldasaroEvangeline Pierce Original Research Open access 16 February 2024 Pages: 1512 - 1525
Lutein and Zeaxanthin Supplementation Improves Dynamic Visual and Cognitive Performance in Children: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study Rajesh ParekhBilly R. Hammond Jr.Divya Chandradhara Original Research Open access 16 February 2024 Pages: 1496 - 1511
7-Year Efficacy and Safety of iStent inject Trabecular Micro-Bypass in Combined and Standalone Usage Fritz H. HengererGerd U. AuffarthIna Conrad-Hengerer Original Research Open access 16 February 2024 Pages: 1481 - 1495
Exposure–Response Efficacy Modeling to Support Trofinetide Dosing in Individuals with Rett Syndrome Mona DarwishJulie PassarellKathie M. Bishop Original Research Open access 16 February 2024 Pages: 1462 - 1480
Development of a Conceptual Model for the Patient Experience of Immunoglobulin A Nephropathy (IgAN): A Qualitative Literature Review Natalie V. J. AldhouseHelen KitchenChristine L. Baker Review Open access 16 February 2024 Pages: 1325 - 1337
Efficacy and Tolerability of Adjunctive Brivaracetam in Patients with Focal-Onset Seizures on Specific Concomitant Antiseizure Medications: Pooled Analysis of Double-Blind, Placebo-Controlled Trials Brian MoseleyDimitrios BourikasSimon Borghs Brief Report Open access 15 February 2024 Pages: 1746 - 1758
Application of Northern Goshawk Back-Propagation Artificial Neural Network in the Prediction of Monohydroxycarbazepine Concentration in Patients with Epilepsy Yichao XuRong ShaoHaibin Dai Original Research 15 February 2024 Pages: 1450 - 1461
Cost-Effectiveness Analysis of Sintilimab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: A Societal Perspective Fuming LiYingyao ChenYi Yang Original Research 15 February 2024 Pages: 1436 - 1449
Respiratory Syncytial Virus (RSV) Burden in Infants in the Kingdom of Saudi Arabia and the Impact of All-Infant RSV Protection: A Modeling Study Adel AlharbiAbdullah YousefMatthieu Beuvelet Original Research Open access 15 February 2024 Pages: 1419 - 1435
Exploring Perceptions of Biologic Therapies: A Qualitative Study Among Canadians Living with Severe Asthma Andrea BeverJessica DunneShelagh M. Szabo Original Research 13 February 2024 Pages: 1401 - 1418
A Response to: Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China” Congling GuYi Han Letter Open access 10 February 2024 Pages: 1762 - 1764
Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China” Kun Huang Letter Open access 10 February 2024 Pages: 1759 - 1761
Risk of Stroke in Real-World US Individuals with Type 2 Diabetes Receiving Semaglutide or a Dipeptidyl Peptidase 4 Inhibitor Marc EvansMansoor HusainIldiko Lingvay Original Research Open access 10 February 2024 Pages: 1843 - 1859
Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy Carla RognoniDomenica LorussoPatrizio Armeni Original Research Open access 08 February 2024 Pages: 1385 - 1400
Contraceptive Recommendations for Women with Immune-Mediated Inflammatory Diseases: A Delphi Consensus José Manuel CarrascosaAna EcharriMaría Montoro Álvarez Original Research 07 February 2024 Pages: 1372 - 1384